PMID- 10570261 OWN - NLM STAT- MEDLINE DCOM- 19991220 LR - 20171116 IS - 0022-1767 (Print) IS - 0022-1767 (Linking) VI - 163 IP - 11 DP - 1999 Dec 1 TI - Differential role for p38 mitogen-activated protein kinase in regulating CD40-induced gene expression in dendritic cells and B cells. PG - 5786-95 AB - We investigated whether human monocyte-derived dendritic cells (DCs) differed from tonsillar B cells in the set of cell fate genes they express constitutively and in the way these genes are affected after CD40 ligation. In particular, Bcl-2, TNF receptor-associated factor-2 (TRAF2), and TRAF4 were clearly inducible via CD40 in B cells but not in DCs. DCs, unlike B cells, were induced to increase expression of IL-1beta, IL-1Ra, IL-8, IL-12 p40, RANTES, macrophage inflammatory protein-1alpha, and monocyte chemoattractant protein-1 after CD40 ligation. We next tested whether CD40-induced signaling pathways were different in DCs vs B cells. In DCs, as in B cells, CD40 ligation activated p38 mitogen-activated protein kinase (MAPK), its downstream target, MAPKAPK-2, and the c-Jun N-terminal kinase. The p38 MAPK-specific inhibitor, SB203580, blocked CD40-induced MAPKAPK-2 activation, but did not affect activation of c-Jun N-terminal kinase. Furthermore, unlike in B cells, extracellular signal-regulated kinase-1 and -2 were activated after CD40 ligation in DCs. SB203580 strongly blocked CD40-induced IL-12 p40 production in DCs at both mRNA and protein levels, while having minimal effect on CD40-induced expression of the chemokine RANTES. In contrast, no detectable IL-12 p40 protein was secreted in CD40-stimulated B cells. Furthermore, CD40-induced mRNA expression of cellular inhibitor of apoptosis protein-2 was also dependent on the p38 MAPK pathway in DCs and differed compared with that in B cells. In conclusion, CD40 induces distinct programs in DCs and B cells, and the set of p38 MAPK-dependent genes in DCs (IL-12 p40 and cellular inhibitor of apoptosis protein-2) is different from that in B cells (IL-10 and IL-1beta). FAU - Aicher, A AU - Aicher A AD - Department of Microbiology, University of Washington, Seattle, WA 98195, USA. FAU - Shu, G L AU - Shu GL FAU - Magaletti, D AU - Magaletti D FAU - Mulvania, T AU - Mulvania T FAU - Pezzutto, A AU - Pezzutto A FAU - Craxton, A AU - Craxton A FAU - Clark, E A AU - Clark EA LA - eng GR - GM37905/GM/NIGMS NIH HHS/United States GR - RR00166/RR/NCRR NIH HHS/United States PT - Comparative Study PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - J Immunol JT - Journal of immunology (Baltimore, Md. : 1950) JID - 2985117R RN - 0 (CD40 Antigens) RN - 0 (Chemokines) RN - 0 (Cytokines) RN - 0 (Inhibitor of Apoptosis Proteins) RN - 0 (Proteins) RN - 0 (Proto-Oncogene Proteins c-bcl-2) RN - 0 (TNF Receptor-Associated Factor 1) RN - 0 (TNF Receptor-Associated Factor 3) RN - 0 (TNF Receptor-Associated Factor 4) RN - 0 (TRAF4 protein, human) RN - 0 (Tumor Necrosis Factor Receptor-Associated Peptides and Proteins) RN - EC 2.7.11.24 (Mitogen-Activated Protein Kinases) RN - EC 2.7.11.24 (p38 Mitogen-Activated Protein Kinases) SB - IM MH - Apoptosis MH - B-Lymphocytes/*immunology MH - CD40 Antigens/*metabolism MH - Chemokines/biosynthesis MH - Cytokines/biosynthesis MH - Dendritic Cells/*immunology MH - Gene Expression Regulation MH - Humans MH - Immunologic Capping MH - Inhibitor of Apoptosis Proteins MH - Mitogen-Activated Protein Kinases/*metabolism MH - Monocytes/immunology MH - Palatine Tonsil/cytology/immunology MH - Protein Biosynthesis MH - *Proteins MH - Proto-Oncogene Proteins c-bcl-2/biosynthesis MH - Signal Transduction MH - TNF Receptor-Associated Factor 1 MH - TNF Receptor-Associated Factor 3 MH - TNF Receptor-Associated Factor 4 MH - Tumor Necrosis Factor Receptor-Associated Peptides and Proteins MH - p38 Mitogen-Activated Protein Kinases EDAT- 1999/11/26 00:00 MHDA- 1999/11/26 00:01 CRDT- 1999/11/26 00:00 PHST- 1999/11/26 00:00 [pubmed] PHST- 1999/11/26 00:01 [medline] PHST- 1999/11/26 00:00 [entrez] AID - ji_v163n11p5786 [pii] PST - ppublish SO - J Immunol. 1999 Dec 1;163(11):5786-95.